---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-036165"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T08:15:13.375867+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cryo-Cell plans spin-off of Celle Corp. and explores strategic alternatives including sale

## Summary
- Board authorized spin-off of newly formed Celle Corp. via stock dividend to Cryo-Cell shareholders.
- Spin-off expected in Q2 or Q3 2024; Celle Corp. holds Duke University license and other assets.
- Company will explore equity/debt financings or possible sale/merger for post-spin-off Cryo-Cell.
- No assurance that any transaction will occur; further details to be disclosed in SEC filings.

## SEC filing metadata
- accession: 0000950170-24-036165
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000095017024036165/0000950170-24-036165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000095017024036165/ccel-20240325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-036165
- JSON: https://secwatch.observer/filing/0000950170-24-036165.json
- Plain text: https://secwatch.observer/filing/0000950170-24-036165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.